Click here to close now.




















Welcome!

News Feed Item

B Cell Study May Lead to Treatment Options for Progressive MS

MS Society of Canada and MS Scientific Research Foundation announce $3.6 million grant to understanding B cells for future MS therapies

TORONTO, ONTARIO -- (Marketwired) -- 02/18/14 -- The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation announced a $3.6 million grant to investigate the role of the B cell, a type of white blood cell of the immune system, in contributing to the development and propagation of multiple sclerosis. With collaboration between McGill University, Universite de Montreal and University of Toronto, world-leading MS experts Drs. Amit Bar-Or, Alexandre Prat and Jennifer Gommerman will engage in a unique interdisciplinary approach to identify and explain the role of B cells in MS.

To date, modern scientific understanding has considered MS to be a disease controlled by the T cell, another type of white blood cell. Research has shown that in MS, T cells mistakenly recognize and attack myelin, the protective layer of fat covering nerves in the central nervous system, exposing them to damage. Research in T cells has led to the development of therapies that aim to control or block the effects of harmful T cells.

However, a surprising discovery in emerging studies has revealed that therapies targeting B cells led to dramatic improvements in people living with MS. Moreover, B cells have recently been found in areas of the brain associated with progressive MS, which is a debilitating form of MS that currently has no treatments. These recent studies have led scientists to believe that B cells, which were previously overlooked in MS, are significant contributors to the disease.

"Based on the encouraging clinical trial results of B cell depletion in people with relapsing-remitting MS, the question is no longer whether B cells are important contributors to MS, but how they contribute," said Dr. Amit Bar-Or, clinician and scientist at the Montreal Neurological Institute at McGill University, and one of the study's lead investigators. "Members of our team have recently discovered that different types of human B cells exist. Some B cells promote inflammation, while others are actually able to limit inflammation. This collaborative study will allow us to address important emerging issues relevant to understanding and better treating MS, especially progressive MS."

"This funding provides a unique occasion to pool scientific resources and expertise from three major MS research centres in Canada to study the influence of B cells in the development of MS," said Dr. Alexandre Prat, neurologist and researcher at the Centre hospitalier de l'Universite de Montreal and professor at the Faculty of Medicine of Universite de Montreal. "It is truly an exciting moment for us, and for the MS community in general."

Drs. Bar-Or, Prat and Gommerman will collaborate to uncover fundamental knowledge about how B cells influence the course of MS. This information will point to clues about the cause of MS, while enabling them to explore the potential of B cell-targeted treatments for people living with all forms of MS.

"Our multi-centre team provides a large range of expertise, from clinical experience to extensive knowledge in immunology. Our collaborative research will accomplish our goal to learn more about B cells in MS, so that one day we could develop therapies for progressive forms of the disease," said Dr. Jennifer Gommerman, scientist and associate professor at the Faculty of Medicine of University of Toronto.

"As Canada has the highest rate of MS in the world, Canadian researchers have a special interest in finding new ways to think about the cause of MS and improve therapies for Canadians living with the disease," said Dr. Karen Lee, vice-president of research, MS Society of Canada. "We are excited that this research team is breaking new ground in the field of MS research that will further our knowledge about the complexity of MS. We believe that an end to MS is achievable, and this B cell study will bring us closer to finding the answers we need and ending MS."

"I think that finding the cause and cure for MS involves innovative thinking and ideas as well as working together to ultimately end this disease," said Andrea Butcher-Milne, who was diagnosed with MS in 1997. "It gives me comfort that researchers in our country are doing their best to realize the promise of a brighter future for people with MS."

This study has been selected by the Canadian Institutes of Health Research to be presented at this month's Cafe Scientifique held on February 18 in Toronto. Cafe Scientifique is an interactive series of presentations that allow scientists to share their research advances to the general public. For more details, visit the Cafe Scientifique website.

About multiple sclerosis and the MS Society of Canada

Canada has the highest rate of multiple sclerosis in the world. MS is a chronic, often disabling disease of the central nervous system comprising the brain, spinal cord and optic nerve. It is the most common neurological disease of young adults in Canada. Most people with MS are diagnosed between the ages of 15 and 40, and the unpredictable effects of MS last for the rest of their lives. The MS Society provides services to people with MS and their families and funds research to find the cause and cure for this disease. Please visit mssociety.ca or call 1-800-268-7582 to make a donation or for more information.

About the Multiple Sclerosis Scientific Research Foundation

The Multiple Sclerosis Scientific Research Foundation funds large, innovative, multi-centre collaborative studies that will lead to major advances in the field of multiple sclerosis. A unique Canadian resource, the Foundation's main funding source is the MS Society of Canada.

The Neuro

The Montreal Neurological Institute and Hospital - The Neuro, is a unique academic medical centre dedicated to neuroscience. Founded in 1934 by the renowned Dr. Wilder Penfield, The Neuro is recognized internationally for integrating research, compassionate patient care and advanced training, all key to advances in science and medicine. The Neuro is a research and teaching institute of McGill University and forms the basis for the Neuroscience Mission of the McGill University Health Centre. Neuro researchers are world leaders in cellular and molecular neuroscience, brain imaging, cognitive neuroscience and the study and treatment of epilepsy, multiple sclerosis and neuromuscular disorders. For more information, visit theneuro.com.

About the Centre hospitalier de l'Universite de Montreal

The Centre hospitalier de l'Universite de Montreal (CHUM) first and foremost provides highly specialized healthcare in all medical specialties to a regional and supra-regional adult clientele. It is the main centre for development and knowledge transfer through its integrated activities in healthcare, teaching, research, assessment of technologies and treatment methods, as well as quality, the promotion of health and the patient experience. As of 2016, the CHUM will offer an improved hospital experience in its new downtown Montreal facilities. The CHUM is an active member of the Reseau universitaire integre de sante (RUIS) de l'Universite de Montreal. chumontreal.qc.ca

About the University of Toronto Faculty of Medicine

The University of Toronto Faculty of Medicine is at the heart of one of the great biomedical research, education and clinical care networks in the world. With nine fully affiliated hospitals and research institutes and 18 community-affiliated hospitals and clinical care sites, the Faculty of Medicine is a research powerhouse that offers unparalleled opportunities for its 6,800 faculty and 8,000-plus students at all levels. Nearly half of Ontario's medical doctors and fully 25 per cent of all health and biomedical PhDs in Canada were trained by the Faculty of Medicine, which consistently ranks among the top medical schools worldwide.

Contacts:
Lindsay Gulin
MS Society of Canada
416-922-6600 x3245
[email protected]

Isabelle Lavigne
Centre hospitalier de l'Universite de Montreal (CHUM)
514-890-8000 x15380
[email protected]

Anita Kar
Montreal Neurological Institute and Hospital
(The Neuro)
514-398-3376
[email protected]

Suniya Kukaswadia
Faculty of Medicine, University of Toronto
416-978-7752
[email protected]

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
Puppet Labs has announced the next major update to its flagship product: Puppet Enterprise 2015.2. This release includes new features providing DevOps teams with clarity, simplicity and additional management capabilities, including an all-new user interface, an interactive graph for visualizing infrastructure code, a new unified agent and broader infrastructure support.
SYS-CON Events announced today that Micron Technology, Inc., a global leader in advanced semiconductor systems, will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Micron’s broad portfolio of high-performance memory technologies – including DRAM, NAND and NOR Flash – is the basis for solid state drives, modules, multichip packages and other system solutions. Backed by more than 35 years of tech...
This Enterprise Strategy Group lab validation report of the NEC Express5800/R320 server with Intel® Xeon® processor presents the benefits of 99.999% uptime NEC fault-tolerant servers that lower overall virtualized server total cost of ownership. This report also includes survey data on the significant costs associated with system outages impacting enterprise and web applications. Click Here to Download Report Now!
SYS-CON Events announced today the Containers & Microservices Bootcamp, being held November 3-4, 2015, in conjunction with 17th Cloud Expo, @ThingsExpo, and @DevOpsSummit at the Santa Clara Convention Center in Santa Clara, CA. This is your chance to get started with the latest technology in the industry. Combined with real-world scenarios and use cases, the Containers and Microservices Bootcamp, led by Janakiram MSV, a Microsoft Regional Director, will include presentations as well as hands-on...
Cloud and datacenter migration innovator AppZero has joined the Microsoft Enterprise Cloud Alliance Program. AppZero is a fast, flexible way to move Windows Server applications from any source machine – physical or virtual – to any destination server, in any cloud or datacenter, using its patented container technology. AppZero’s container is also called a Virtual Application Appliance (VAA). To facilitate Microsoft Azure onboarding, AppZero has two purpose-built offerings: AppZero SP for Azure,...
It’s been proven time and time again that in tech, diversity drives greater innovation, better team productivity and greater profits and market share. So what can we do in our DevOps teams to embrace diversity and help transform the culture of development and operations into a true “DevOps” team? In her session at DevOps Summit, Stefana Muller, Director, Product Management – Continuous Delivery at CA Technologies, answered that question citing examples, showing how to create opportunities for ...
SYS-CON Events announced today that Pythian, a global IT services company specializing in helping companies leverage disruptive technologies to optimize revenue-generating systems, has been named “Bronze Sponsor” of SYS-CON's 17th Cloud Expo, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Founded in 1997, Pythian is a global IT services company that helps companies compete by adopting disruptive technologies such as cloud, Big Data, advance...
A producer of the first smartphones and tablets, presenter Lee M. Williams will talk about how he is now applying his experience in mobile technology to the design and development of the next generation of Environmental and Sustainability Services at ETwater. In his session at @ThingsExpo, Lee Williams, COO of ETwater, will talk about how he is now applying his experience in mobile technology to the design and development of the next generation of Environmental and Sustainability Services at ET...
While many app developers are comfortable building apps for the smartphone, there is a whole new world out there. In his session at @ThingsExpo, Narayan Sainaney, Co-founder and CTO of Mojio, will discuss how the business case for connected car apps is growing and, with open platform companies having already done the heavy lifting, there really is no barrier to entry.
SYS-CON Events announced today that HPM Networks will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. For 20 years, HPM Networks has been integrating technology solutions that solve complex business challenges. HPM Networks has designed solutions for both SMB and enterprise customers throughout the San Francisco Bay Area.
Everyone talks about continuous integration and continuous delivery but those are just two ends of the pipeline. In the middle of DevOps is continuous testing (CT), and many organizations are struggling to implement continuous testing effectively. After all, without continuous testing there is no delivery. And Lab-As-A-Service (LaaS) enhances the CT with dynamic on-demand self-serve test topologies. CT together with LAAS make a powerful combination that perfectly serves complex software developm...
As more and more data is generated from a variety of connected devices, the need to get insights from this data and predict future behavior and trends is increasingly essential for businesses. Real-time stream processing is needed in a variety of different industries such as Manufacturing, Oil and Gas, Automobile, Finance, Online Retail, Smart Grids, and Healthcare. Azure Stream Analytics is a fully managed distributed stream computation service that provides low latency, scalable processing of ...
As more intelligent IoT applications shift into gear, they’re merging into the ever-increasing traffic flow of the Internet. It won’t be long before we experience bottlenecks, as IoT traffic peaks during rush hours. Organizations that are unprepared will find themselves by the side of the road unable to cross back into the fast lane. As billions of new devices begin to communicate and exchange data – will your infrastructure be scalable enough to handle this new interconnected world?
Culture is the most important ingredient of DevOps. The challenge for most organizations is defining and communicating a vision of beneficial DevOps culture for their organizations, and then facilitating the changes needed to achieve that. Often this comes down to an ability to provide true leadership. As a CIO, are your direct reports IT managers or are they IT leaders? The hard truth is that many IT managers have risen through the ranks based on their technical skills, not their leadership ab...
IBM’s Blue Box Cloud, powered by OpenStack, is now available in any of IBM’s globally integrated cloud data centers running SoftLayer infrastructure. Less than 90 days after its acquisition of Blue Box, IBM has integrated its Blue Box Cloud Dedicated private-cloud-as-a-service into its broader portfolio of OpenStack® based solutions. The announcement, made today at the OpenStack Silicon Valley event, further highlights IBM’s continued support to deliver OpenStack solutions across all cloud depl...